Ultragenyx Pharmaceutical Inc. (RARE) compared with its closest peers (AXSM, SUPN, AMPH, EBS, OPK). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Axsome Therapeutics, Supernus Pharmaceuticals, Amphastar Pharmaceuticals, Emergent BioSolutions, OPKO Health, Insmed, Corcept Therapeutics, Catalyst Pharmaceuticals, Collegium Pharmaceutical and Organogenesis share Ultragenyx Pharmaceutical's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.66B | -73.0 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Catalyst Pharmaceuticals, Inc. (CPRX) | $3.85B | 17.1 |
| Collegium Pharmaceutical, Inc. (COLL) | $882.75M | 19.4 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
RARE overview · RARE earnings · RARE financials · RARE KPIs · RARE documents · RARE ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.